Phillip Levy, M.D., M.P.H., has been appointed associate vice president for Translational Sciences at Wayne State University.

In this position, Dr. Levy will provide senior leadership for the next phase of development of translational and clinical sciences for the university and the communities it serves.

The appointment was announced Aug. 23 by Stephen Lanier, Ph.D., vice president for Research for the university, and Wael Sakr, M.D., dean of the School of Medicine.

A professor in the Department of Emergency Medicine, Dr. Levy has served as assistant vice president for Translational Sciences and Clinical Research Innovation since 2016.

Dr. Levy and his team have developed strong platforms for bioinformatics and data integration through a virtual data warehouse that can be used to drive population-level health improvement in ways that have the potential to address health inequities and for informed clinical trial design and community partnerships.

Since April 2020, he has led the Wayne State University and Wayne Health Mobile Health Unit program, which has brought COVID-19 testing, vaccinations and a range of other health services to nearly 55,000 people in Michigan.

Dr. Levy is the principal investigator for ACHIEVE GREATER (Addressing Cardiometabolic Health Inequities by Early PreVEntion in the GREAT LakEs Region) (P50 MD017351-01), a new center grant funded by the National Institute on Minority Health and Health Disparities of the National Institutes of Health that focuses on population level risk reduction. He is also the principal investigator for LEAP HTN (Linkage, Empowerment, and Access to Prevent Hypertension), which is part of the RESTORE Health Equity Research Network funded by the American Heart Association. He is the program director for the Detroit Cardiovascular Training Program (T32 HL120822-10).